HeartFlow Analyst Price Targets - Benzinga

HeartFlow Inc

HTFLNASDAQ

Trade with Public

Trade with Public

$49.75

-0.08-0.16%

Últ. Act.: Sep 30, 4:26 PM

$49.75

-0.08-0.16%

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Opciones Informe de acciones

HeartFlow Analyst Price Targets - Benzinga

HeartFlow Analyst Price Targets

Wall Street analyst price targets and consensus rating for HeartFlow (HTFL).

Price Target Range — 5 Quarters

Analyst Consensus — 9 Analysts

8Buy

1Hold

Consensus RatingOverweight# Analysts9Avg. Consensus PT$44Upside to Avg. PT-11.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 22, 2026	Canaccord Genuity	William Plovanic	PT Raise	Buy	$45→$56
Sep 9, 2026	UBS	Doug Schenkel	Initiate	Neutral	$55
Aug 14, 2026	Canaccord Genuity	William Plovanic	PT Raise	Buy	$37→$45
Aug 14, 2026	Morgan Stanley	Patrick Wood	PT Raise	Equal-Weight	$35→$40
Aug 14, 2026	Stifel	Rick Wise	PT Raise	Buy	$40→$45
Aug 14, 2026	Piper Sandler	Matt OBrien	PT Raise	Overweight	$38→$45
Aug 14, 2026	JP Morgan	Robbie Marcus	PT Raise	Overweight	$35→$45
Aug 14, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$37→$39
Jul 31, 2026	Baird	David Rescott	Initiate	Outperform	$34
Jul 1, 2026	Freedom Capital Markets	Gene Mannheimer	Initiate	Buy	$37
May 15, 2026	Canaccord Genuity	William Plovanic	PT Cut	Buy	$43→$37
May 15, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$35→$37
May 4, 2026	William Blair	Brandon Vazquez	Initiate	Outperform	—
Mar 19, 2026	JP Morgan	Robbie Marcus	PT Cut	Overweight	$40→$35
Mar 19, 2026	Canaccord Genuity	William Plovanic	PT Raise	Buy	$40→$43
Mar 19, 2026	Wells Fargo	Larry Biegelsen	PT Cut	Overweight	$38→$35
Mar 9, 2026	Canaccord Genuity	William Plovanic	Maintained	Buy	$40
Jan 28, 2026	Wells Fargo	Larry Biegelsen	Initiate	Overweight	$38
Nov 13, 2025	Canaccord Genuity	William Plovanic	PT Raise	Buy	$39→$40
Nov 13, 2025	JP Morgan	Robbie Marcus	PT Raise	Overweight	$36→$40

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $56

Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and raises the price target from $45 to $56.

Benzinga Newsdesk

PRO
UBS Initiates Coverage On HeartFlow with Neutral Rating, Announces Price Target of $55

UBS analyst Doug Schenkel initiates coverage on HeartFlow (NASDAQ:HTFL) with a Neutral rating and announces Price Target of $55.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $45

Canaccord Genuity analyst William Plovanic maintains HeartFlow (NASDAQ:HTFL) with a Buy and raises the price target from $37 to $45.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Equal-Weight on HeartFlow, Raises Price Target to $40

Morgan Stanley analyst Patrick Wood maintains HeartFlow (NASDAQ:HTFL) with a Equal-Weight and raises the price target from $35 to $40.

Benzinga Newsdesk

PRO
Piper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $45

Piper Sandler analyst Matt OBrien reiterates HeartFlow (NASDAQ:HTFL) with a Overweight and raises the price target from $38 to $45.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on HeartFlow, Raises Price Target to $45

JP Morgan analyst Robbie Marcus maintains HeartFlow (NASDAQ:HTFL) with a Overweight and raises the price target from $35 to $45.

Benzinga Newsdesk